45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
8,322
Insurances with rates
13
CPT / HCPCS codes
7,362
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J7181 | TRETTEN 2,500 UNIT INTRAVENOUS SOLUTION | $369,210 | $369,210 | — | — | 2 |
| J0225 | AMVUTTRA 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $272,120 | $272,120 | — | — | 1 |
| J2351 | OCREVUS ZUNOVO 920 MG-23,000 UNIT/23 ML SUBCUTANEOUS SOLUTION | $193,199 | $193,199 | — | — | 2 |
| J9228 | YERVOY 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $160,812 | $160,812 | — | — | 6 |
| J9999 | GLIADEL WAFER 7.7 MG IMPLANT | $131,789 | $131,789 | — | — | 4 |
| J9226 | SUPPRELIN LA 50 MG (65 MCG/DAY) IMPLANT KIT | $114,414 | $114,414 | — | — | 4 |
| A9540 | DRAXIMAGE MAA 2.5 MG INTRAVENOUS SOLUTION | $105,719 | $105,719 | — | — | 4 |
| 33264 | Rmvl Pcd W/Rplc Mult Lead | $96,185 | $96,185 | — | — | 6 |
| 33231 | Insrt Icd Genrtr W/Exst Mult Leads | $96,185 | $96,185 | — | — | 2 |
| J9028 | ANKTIVA 400 MCG/0.4 ML INTRAVESICAL SOLUTION | $81,624 | $81,624 | — | — | 2 |
| 0916T | Insj Perm Ccm-D Sys Pg Only | $70,706 | $70,706 | — | — | 21 |
| 0923T | Rmvl&Rplcmt Perm Ccm-D Pg | $70,706 | $70,706 | — | — | 2 |
| J0202 | LEMTRADA 12 MG/1.2 ML INTRAVENOUS SOLUTION | $67,817 | $67,817 | — | — | 11 |
| J9345 | ZYNYZ 500 MG/20 ML INTRAVENOUS SOLUTION | $66,769 | $66,769 | — | — | 2 |
| J9359 | ZYNLONTA 10 MG INTRAVENOUS SOLUTION | $66,188 | $66,188 | — | — | 2 |
| J1246 | UNITUXIN 3.5 MG/ML INTRAVENOUS SOLUTION | $65,311 | $65,311 | — | — | 15 |
| J9316 | PHESGO 1,200 MG-600 MG-30,000 UNIT/15 ML SUBCUTANEOUS SOLUTION | $65,129 | $65,129 | — | — | 2 |
| J2267 | OMVOH 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION | $61,013 | $61,013 | — | — | 18 |
| J7209 | NUWIQ 4,000 UNIT INTRAVENOUS SOLUTION | $58,032 | $58,032 | — | — | 24 |
| J2327 | SKYRIZI 360 MG/2.4 ML (150 MG/ML) SUBCUTANEOUS WEARABLE INJECTOR | $54,352 | $54,352 | — | — | 20 |
| 37184 | Percutaneous Thrombectomy Prim | $53,870 | $53,870 | — | — | 25 |
| J3316 | TRIPTODUR 22.5 MG IM SUSPENSION | $52,364 | $52,364 | — | — | 18 |
| J9022 | TECENTRIQ 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $51,457 | $51,457 | — | — | 2 |
| J9024 | TECENTRIQ HYBREZA 1,875 MG-30,000 UNIT/15 ML SUBCUTANEOUS SOLUTION | $51,457 | $51,457 | — | — | 4 |
| J0638 | ILARIS (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $51,121 | $51,121 | — | — | 2 |
| C1882 | DEFIB CBLT SURESCN XT CRTD MRI 1/EA DTPA2D4 | $50,850 | $50,850 | — | — | 2 |
| J7198 | FEIBA NF 1,750 UNIT-3,250 UNIT INTRAVENOUS SOLUTION | $50,220 | $50,220 | — | — | 24 |
| J9274 | KIMMTRAK 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $49,043 | $49,043 | — | — | 1 |
| C2616 | Y90 Dose | $48,421 | $48,421 | — | — | 4 |
| 0636 | IMBRUVICA 140 MG TABLET | $47,568 | $47,568 | — | — | 18 |
| J1323 | ELREXFIO 40 MG/ML SUBCUTANEOUS SOLUTION | $46,356 | $46,356 | — | — | 14 |
| J1561 | GAMUNEX-C 40 GRAM/400 ML (10 %) INJECTION SOLUTION | $45,592 | $45,592 | — | — | 6 |
| 93654 | Comp Ep Eval W/Ablation for V-Tach | $44,953 | $44,953 | — | — | 19 |
| J3263 | LOQTORZI 240 MG/6 ML (40 MG/ML) INTRAVENOUS SOLUTION | $43,322 | $43,322 | — | — | 5 |
| J0139 | HUMIRA(CF) PEN 80 MG/0.8 ML SUBCUTANEOUS KIT | $43,197 | $43,197 | — | — | 19 |
| J3245 | ILUMYA 100 MG/ML SUBCUTANEOUS SYRINGE | $40,952 | $40,952 | — | — | 2 |
| J9228 | YERVOY 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION | $40,203 | $40,203 | — | — | 18 |
| J9332 | VYVGART 20 MG/ML INTRAVENOUS SOLUTION | $40,158 | $40,158 | — | — | 6 |
| J9301 | GAZYVA 1,000 MG/40 ML INTRAVENOUS SOLUTION | $39,961 | $39,961 | — | — | 2 |
| C9767 | Fem/Pop Art Stent/Arthrect/Pta | $39,114 | $39,114 | — | — | 5 |
| C9775 | Revasc Lith-Sten-Ath Tib/Per | $39,114 | $39,114 | — | — | 2 |
| 27759 | Treat Tibial Shaft Fx, Intramed Implant | $38,600 | $38,600 | — | — | 2 |
| 36906 | Perq Thrmbc/Nfs Dial Circuit Tcat Plmt IV Stent | $38,263 | $38,263 | — | — | 6 |
| 33274 | Tcat Insj/Rpl Perm Leadless Pacemaker Rv W/Img | $38,000 | $38,000 | — | — | 6 |
| 93582 | Perq Transcath Closure Pda | $37,893 | $37,893 | — | — | 19 |
| 92937 | Cor Graft Athrctmy W/Stent - 1 Vsl | $37,226 | $37,226 | — | — | 2 |
| J7209 | NUWIQ 2,500 UNIT INTRAVENOUS SOLUTION | $36,270 | $36,270 | — | — | 2 |
| J0491 | SAPHNELO 300 MG/2 ML (150 MG/ML) INTRAVENOUS SOLUTION | $35,122 | $35,122 | — | — | 2 |
| J3357 | STELARA 45 MG/0.5 ML SUBCUTANEOUS SOLUTION | $34,894 | $34,894 | — | — | 6 |
| C1721 | DEFIB COBALT SURESCN XT DR MRI 1/EA DDPA2D4 | $34,458 | $34,458 | — | — | 2 |
Showing top 50 of 8,322 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.